Prospective Study on the Clinical Effectiveness, Safety, Cost Benefits, and Outcomes of the SoundBite™ Crossing System in Complex Peripheral CTOs - The PROSPECTOR II Study

Status: Withdrawn
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims at assessing additional performance characteristics of the SoundBite™ Crossing System with regards to the luminal passage of complex Chronic Total Occlusions (CTO) by evaluating clinically relevant efficacy, safety, cost benefit and treatment pathway endpoints.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Has symptomatic non-acute limb ischemia, requiring treatment of an infrainguinal artery

• Has Rutherford Clinical Category of 2-6

• is able and willing to provide written informed consent prior to study procedure

⁃ Angiographic Inclusion Criteria

• 100% stenosis by a visual estimate of angiography at the time of the procedure

• target CTO has moderate to severe calcification

• Has at least one of the following: severe calcification, flush occlusion, femoropopliteal CTOs with reconstitution below Popliteal 2-3, side directing collateral at the proximal cap, long (≥ 5cm) occlusions, below the knee (BTK) occlusion.

• Has evidence of a clinically significant CTO located in a peripheral vessel below the infrainguinal ligament confirmed by angiography at time of the procedure.

Locations
Other Locations
Austria
Medical University of Graz
Graz
Germany
Klinikum Hochsauerland GmbH, Klinik für Angiologie
Arnsberg
Time Frame
Start Date: 2022-12-30
Completion Date: 2023-09-30
Treatments
Experimental: SoundBite™ Crossing System - Peripheral
SoundBite™ Crossing System-Peripheral is indicated to facilitate the intraluminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions via atherectomy.
Sponsors
Collaborators: ethica Clinical Research Inc., Montreal Heart Institute
Leads: SoundBite Medical Solutions, Inc.

This content was sourced from clinicaltrials.gov

Similar Clinical Trials